Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. GL
stocks logo

GL

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
1.50B
+4.47%
3.257
+9.66%
1.52B
+4.59%
3.846
+10.2%
1.54B
+5.01%
3.487
+11.05%
Estimates Revision
The market is revising Downward the revenue expectations for Globe Life Inc. (GL) for FY2025, with the revenue forecasts being adjusted by -0.13% over the past three months. During the same period, the stock price has changed by -7.09%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.13%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-0.35%
In Past 3 Month
Stock Price
Go Down
down Image
-7.09%
In Past 3 Month
10 Analyst Rating
up Image0
Wall Street analysts forecast GL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GL is 137.20 USD with a low forecast of 118.00 USD and a high forecast of 168.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Buy
4 Hold
0 Sell
Moderate Buy
up Image0
Current: 120.590
sliders
Low
118.00
Averages
137.20
High
168.00
up Image0
Current: 120.590
sliders
Low
118.00
Averages
137.20
High
168.00
Morgan Stanley
Equal Weight
maintain
$117 -> $125
2025-05-19
Reason
Morgan Stanley
Price Target
$117 -> $125
2025-05-19
maintain
Equal Weight
Reason
Morgan Stanley raised the firm's price target on Globe Life to $125 from $117 and keeps an Equal Weight rating on the shares. The firm is updating its price targets on stocks under its coverage in the Life Insurance sector, the analyst tells investors. Morgan Stanley notes core results held up well and a rebound is expected to occur in 2H25. Overall, valuation is attractive for the sector, the firm says.
Wells Fargo
Elyse Greenspan
Buy
Maintains
$141 → $140
2025-04-10
Reason
Wells Fargo
Elyse Greenspan
Price Target
$141 → $140
2025-04-10
Maintains
Buy
Reason
Wells Fargo lowered the firm's price target on Globe Life to $140 from $141 and keeps an Overweight rating on the shares. The firm notes that the quarter lost a little luster with the tariff backdrop and Wells thinks a bigger focus will be on any views of tariffs/ensuring macro backdrop.
Morgan Stanley
Nigel Dally
Hold
Maintains
$126 → $117
2025-04-10
Reason
Morgan Stanley
Nigel Dally
Price Target
$126 → $117
2025-04-10
Maintains
Hold
Reason
Morgan Stanley analyst Bob Huang lowered the firm's price target on Globe Life to $117 from $126 and keeps an Equal Weight rating on the shares. On average across the firm's life insurance coverage, Q1 EPS estimates declined 3% from prior estimates and its 2025 EPS estimates declined 4% from prior estimates, though results vary across companies, notes the analyst in a preview for the group. For underwriting-oriented companies that should not be as sensitive to equity market fluctuations, the firm's estimates generally did not change as much, but it still moved underwriter estimates down as they likely face an incrementally more challenging operating environment, the analyst noted.
Piper Sandler
John Barnidge
Buy
Maintains
$140 → $152
2025-04-02
Reason
Piper Sandler
John Barnidge
Price Target
$140 → $152
2025-04-02
Maintains
Buy
Reason
Piper Sandler raised the firm's price target on Aflac (AFL) to $124 from $118 and keeps an Overweight rating on the shares. The firm is generally reducing EPS estimates for the group driven by fee and spread headwinds, and favors underwriting areas of lifecoland as a result. Fee businesses have client outflows, less fee and trading days and seasonally higher expenses. Spread has prospect of variable investment income normalization being pushed out, floater impact and possible negative commentary around prospective spread income expectations in Piper's opinion. The firm highlights Aflac and Globe Life (GL) among its Overweight names with both primarily focused on the underwriting portion of the industry.
JP Morgan
Jimmy Bhullar
Buy
Maintains
$136 → $145
2025-04-02
Reason
JP Morgan
Jimmy Bhullar
Price Target
$136 → $145
2025-04-02
Maintains
Buy
Reason
Morgan Stanley
Nigel Dally
Hold
Maintains
$125 → $126
2025-02-28
Reason
Morgan Stanley
Nigel Dally
Price Target
$125 → $126
2025-02-28
Maintains
Hold
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Globe Life Inc (GL.N) is 8.56, compared to its 5-year average forward P/E of 10.76. For a more detailed relative valuation and DCF analysis to assess Globe Life Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
10.76
Current PE
8.56
Overvalued PE
12.65
Undervalued PE
8.87

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average EV/EBITDA
9.65
Current EV/EBITDA
8.13
Overvalued EV/EBITDA
11.21
Undervalued EV/EBITDA
8.08

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
1.82
Current PS
1.64
Overvalued PS
2.05
Undervalued PS
1.60

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 1440.51% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

GL News & Events

Events Timeline

(ET)
2025-04-30
16:26:16
Globe Life reports Q1 EPS $3.07, consensus $3.24
select
2024-12-04 (ET)
2024-12-04
13:40:14
Viceroy Research says 'something seriously wrong' at Globe Life's AIL
select
link
2024-12-04
13:34:02
Globe Life refutes 'false' short seller report
select
Sign Up For More Events
Sign Up For More Events

News

Preview
4.5
05-22NASDAQ.COM
Pre-Market Most Active for May 22, 2025 : QBTS, BBAI, HIMS, NEE, T, GLW

  • Pre-Market Indicator and Volume: The NASDAQ 100 Pre-Market Indicator is down by 29.56 points to 21,050.8, with a total pre-market volume of 169,356,894 shares traded.

  • Active Stocks Overview: Notable active stocks include D-Wave Quantum Inc. (QBTS) down to $15.09, Hims & Hers Health, Inc. (HIMS) down to $52.15, and NextEra Energy, Inc. (NEE) down to $68.70, all with varying trading volumes and recommendations in the "buy range."

Preview
4.0
05-20Benzinga
A Glimpse Into The Expert Outlook On Globe Life Through 9 Analysts

  • Analyst Ratings Overview: Globe Life has received mixed evaluations from 9 analysts over the past three months, with recent ratings showing a shift towards more bearish sentiments, while the average price target has increased slightly to $136.89.

  • Financial Performance Indicators: Globe Life demonstrates strong financial health with impressive revenue growth of 4.54%, a net margin of 17.2%, and a debt-to-equity ratio of 0.52, indicating effective management and profitability compared to industry averages.

Preview
6.0
05-19Benzinga
Morgan Stanley Maintains Equal-Weight on Globe Life, Raises Price Target to $125

  • Real-time Intelligence for Traders: Benzinga Pro offers the fastest news alerts and exclusive stories to help traders make informed decisions in the stock market.

  • Community of Serious Traders: Over 10,000 traders are part of the Benzinga Pro community, benefiting from accurate market intelligence and insights.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Globe Life Inc (GL) stock price today?

The current price of GL is 120.59 USD — it has increased 0.74 % in the last trading day.

arrow icon

What is Globe Life Inc (GL)'s business?

Globe Life Inc. is an insurance holding company. Its primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. The Company’s segments include life insurance, supplemental health insurance, and investments. Life insurance products include traditional whole life and term life insurance. The Company offers Medicare Supplement and limited-benefit supplemental health insurance products that include accident, cancer, critical illness, heart, intensive care, and other health products. These products are designed to supplement health coverage that applicants already own. Medicare Supplements are offered to enrollees in the traditional fee-for-service Medicare program. Medicare Supplement plans are standardized by federal regulation and are designed to pay deductibles and co-payments not paid by Medicare.

arrow icon

What is the price predicton of GL Stock?

Wall Street analysts forecast GL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GL is 137.20 USD with a low forecast of 118.00 USD and a high forecast of 168.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Globe Life Inc (GL)'s revenue for the last quarter?

Globe Life Inc revenue for the last quarter amounts to 1.48B USD, increased 4.54 % YoY.

arrow icon

What is Globe Life Inc (GL)'s earnings per share (EPS) for the last quarter?

Globe Life Inc. EPS for the last quarter amounts to 3.01 USD, increased 12.73 % YoY.

arrow icon

What changes have occurred in the market's expectations for Globe Life Inc (GL)'s fundamentals?

The market is revising Downward the revenue expectations for Globe Life Inc. (GL) for FY2025, with the revenue forecasts being adjusted by -0.13% over the past three months. During the same period, the stock price has changed by -7.09%.
arrow icon

How many employees does Globe Life Inc (GL). have?

Globe Life Inc (GL) has 3732 emplpoyees as of June 23 2025.

arrow icon

What is Globe Life Inc (GL) market cap?

Today GL has the market capitalization of 9.95B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free